Chart: PLMA Paints Picture Of Persistent Private Label Penetration
This article was originally published in The Tan Sheet
You may also be interested in...
Perrigo prioritized correcting manufacturing problems that drew an FDA warning, advising the firm to prevent human errors with tighter quality control, according to CEO Joseph Papa
Perrigo promotes in pricing, planning
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC